Anthocyanin extracted from Hibiscus attenuate oxidized LDL-mediated foam cell formation involving regulation of CD36 gene

Chemico-Biological Interactions

Volumn 179, Issue 2-3, 2009, Pages 212-218

  Kao, Erl Shyh ^a   Tseng, Tsui Hwa ^b   Lee, Huei Jane ^b   Chan, Kuei Chuan ^c   Wang, Chau Jong ^b  

^a CHIENKUO TECHNOLOGY UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Anthocyanins; CD36; Hibiscus sabdariffa Linnaeus; LDL oxidation; Macrophage; PPAR

Indexed keywords

ANTHOCYANIN; CD36 ANTIGEN; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SCAVENGER RECEPTOR; UPSTREAM STIMULATORY FACTOR;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG ISOLATION; DRUG MECHANISM; FOAM CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC REGULATION; HIBISCUS; LIPID STORAGE; MACROPHAGE; MICROBIAL ATTENUATION; MOUSE; NONHUMAN; OXIDATION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION;

ANIMALS; ANTHOCYANINS; ANTIGENS, CD36; CELLS, CULTURED; FOAM CELLS; HIBISCUS; LIPOPROTEINS, LDL; MACROPHAGES; MICE; OXIDATION-REDUCTION; PLANT EXTRACTS; PPAR GAMMA; RNA, MESSENGER;

HIBISCUS; HIBISCUS SABDARIFFA; ORYCTOLAGUS CUNICULUS;

EID: 62549091399     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.01.009     Document Type: Article

References (49)

1. Rusinol A.E., Yang L., Thewke D., Panini S.R., Kramer M.F., and Sinensky M.S. Isolation of a somatic cell mutant resistant to the induction of apoptosis by oxidized low density lipoprotein. J. Biol. Chem. 275 (2000) 7296-7303
2. Witztum J.L., and Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88 (1991) 1785-1792
3. Febbraio M., Hajjar D.P., and Silverstein R.L. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108 (2001) 785-791
4. Han J., Hajjar D.P., Febbraio M., and Nicholson A.C. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J. Biol. Chem. 272 (1997) 21654-21659
5. Shaish A., Daugherty A., O'Sullivan F., Schonfeld G., and Heinecke J.W. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J. Clin. Invest. 96 (1995) 2075-2082
6. +-mediated oxidative modification of low-density lipoprotein. Biol. Pharm. Bull. 18 (1995) 1-4
7. Yoshida H., Ishikawa T., Hosoai H., Suzukawa M., Ayaori M., Hisada T., Sawada S., Yonemura A., Higashi K., Ito T., Nakajima K., Yamashita T., Tomiyasu K., Nishiwaki M., Ohsuzu F., and Nakamura H. Inhibitory effect of tea flavonoids on the ability of cells to oxidize low-density lipoprotein. Biochem. Pharmacol. 58 (1999) 1695-1703
8. 2+, AAPH or SIN-1 and at decreasing superoxide THP-1 cell production: a comparison to other extracts or compounds. Free Radic. Res. 37 (2003) 573-584
9. Haji Faraji M., and Haji Tarkhani A. The effect of sour tea (Hibiscus sabdariffa) on essential hypertension. J. Ethnopharmacol. 65 (1999) 231-236
10. Onyenekwe P.C., Ajani E.O., Ameh D.A., and Gamaniel K.S. Antihypertensive effect of roselle (Hibiscus sabdariffa) calyx infusion in spontaneously hypertensive rats and a comparison of its toxicity with that Wistar rats. Cell Biochem. Funct. 17 (1999) 199-206
11. Muller B.M., and Franz G. Chemical structure and biological activity of polysaccharides from Hibiscus sabdariffa. Planta Med. 58 (1992) 60-67
12. Tseng T.H., Kao T.W., Chu C.Y., Chou F.P., Lin W.L., and Wang C.J. Induction of apoptosis Hibiscus protocatechuic acid in human leukemia cells via reduction of retinoblastoma (RB) phosphorylation and Bcl-2 expression. Biochem. Pharmacol. 60 (2000) 307-315
13. Chen C.C., Hsu J.D., Wang S.F., Chiang H.C., Yang M.Y., Kao E.S., Ho Y.C., and Wang C.J. Hibiscus sabdariffa extract inhibits the development of atherosclerosis in cholesterol-fed rabbits. J. Agric. Food Chem. 51 (2003) 5472-5477
14. Wang C.J., Wang J.M., Lin W.L., Chu C.Y., Chou F.P., and Tseng T.H. Protective effect of Hibiscus anthocyanins against tert-butyl hydroperoxide-induced hepatic toxicity in rats. Food Chem. Toxicol. 38 (2000) 411-416
15. Tseng T.H., Wang C.J., Kao E.S., and Chu H.Y. Hibiscus protocatechuic acid protects against oxidative damage induced by tert-butylhydroperoxide in rat primary hepatocytes. Chem. Biol. Interact. 101 (1996) 137-148
16. Lee M.J., Chou F.P., Tseng T.H., Hsieh M.H., Lin M.C., and Wang C.J. Hibiscus protocatechuic acid or esculetin can inhibit oxidative LDL induced by either copper ion or nitric oxide donor. J. Agric. Food Chem. 50 (2002) 2130-2136
17. Chang Y.C., Huang K.X., Huang A.C., Ho Y.C., and Wang C.J. Hibiscus anthocyanins-rich extract inhibited LDL oxidation and oxLDL-mediated macrophages apoptosis. Food Chem. Toxicol. 44 (2006) 1015-1023
18. Chang Y.C., Huang H.P., Hsu J.D., Yang S.F., and Wang C.J. Hibiscus anthocyanins rich extract-induced apoptotic cell death in human promyelocytic leukemia cells. Toxicol. Appl. Pharmacol. 205 (2005) 201-212
19. Havel R.J., Eder H.A., and Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34 (1955) 1345-1353
20. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
21. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15 (1976) 212-216
22. Hsu H.Y. Tumor necrosis factor-α-mediated protein kinases in regulation of scavenger receptor and foam cell formation on macrophage. J. Biol. Chem. 275 (2000) 41035-41048
23. Kao E.S., Wang C.J., Lin L.W., Chu C.Y., and Tseng T.H. Effects of polyphenols derived from fruit of Crataegus pinnatifida on cell transformation, dermal edema and skin tumor formation by phorbol ester application. Food Chem. Toxicol. 45 (2007) 1795-1804
24. Itabe H. Oxidized low-density lipoproteins: what is understood and what remains to be clarified. Biol. Pharm. Bull. 26 (2003) 1-9
25. Nicholson A.C., and Hajjar D.P. CD36, oxidized LDL and PPARγ: pathological interactions in macrophages and atherosclerosis. Vascul. Pharmacol. 41 (2005) 139-146
26. Ma X., Bacci S., Mlynarski W., Gottardo L., Soccio T., Menzaghi C., Iori E., Lager R.A., Shroff A.R., Gervino E.V., Nesto R.W., Johnstone M.T., Abumrad N.A., Avogaro A., Trischitta V., and Doria A. A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum. Mol. Genet. 13 (2004) 2197-2205
27. Kuang M., Febbraio M., Wagg C., Lopaschuk G.D., and Dyck J.R. Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia. Circulation 109 (2004) 1550-1557
28. Cho S., Park E.M., Febbraio M., Anrather J., Park L., Racchumi G., Silverstein R.L., and Iadecola C. The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia. J. Neurosci. 25 (2005) 2504-2512
29. Simantov R., Febbraio M., and Silverstein R.L. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein. Matrix Biol. 24 (2005) 27-34
30. Huang H., Campbell S.C., Bedford D.F., Nelius T., Veliceasa D., Shroff E.H., Henkin J., Schneider A., Bouck N., and Volpert O.V. Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510. Mol. Cancer Res. 2 (2004) 541-550
31. Corpeleijn E., van der Kallen C.J., Kruijshoop M., Magagnin M.G., de Bruin T.W., Feskens E.J., Saris W.H., and Blaak E.E. Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with type 2 diabetes mellitus and insulin resistance. Diabet. Med. 23 (2006) 907-911
32. Leprêtre F., Vasseur F., Vaxillaire M., Scherer P.E., Ali S., Linton K., Aitman T., and Froguel P. A CD36 nonsense mutation associated with insulin resistance and familial type 2 diabetes. Hum. Mutat. 24 (2004) 104
33. Koonen D.P., Glatz J.F., Bonen A., and Luiken J.J. Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. Biochim. Biophys. Acta 1736 (2005) 163-180
34. Kunjathoor V.V., Febbraio M., Podrez E.A., Moore K.J., Andersson L., Koehn S., Rhee J.S., Silverstein R., Hoff H.F., and Freeman M.W. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 277 (2002) 49982-49988
35. Luangarth V., Brodeur M.R., Rhainds D., and Brissette L. Mouse CD36 has opposite effects on LDL and oxidized LDL metabolism in vivo. Arterioscler. Thromb. Vasc. Biol. 28 7 (2008) 1290-1295
36. Rahaman S.O., Lennon D.J., Febbraio M., Podrez E.A., Hazen S.L., and Silverstein R.L. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab. 4 (2006) 211-221
37. Tontonoz P., Hu E., and Spiegelman B. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr. Opin. Genet. Dev. 5 (1995) 571-576
38. Chawla A., Barak Y., Nagy L., Liao D., Tontonoz P., and Evans R.M. PPARγ-dependent and -independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 7 (2001) 48-52
39. Moore K.J., Rosen E.D., Fitzgerald M.L., Randow F., Andersson L.P., Altshuler D., Milstone D.S., Mortensen R.M., Spiegelman B.M., and Freeman M.W. The role of PPARγ in macrophage differentiation and cholesterol uptake. Nat. Med. 7 (2001) 41-47
40. Hofmann C.S., and Sonenshein G.E. Green tea polyphenols epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53. FASEB J. 17 (2003) 702-704
41. Xia M., Hou M., Zhu H., Ma J., Tang Z., Wang Q., Li Y., Chi D., Yu X., Zhao T., Han P., Xia X., and Ling W. Anthocyanins induce cholesterol efflux from mouse peritoneal macrophages: the role of the peroxisome proliferator-activated receptor {gamma}-liver X receptor {alpha}-ABCA1 pathway. J. Biol. Chem. 280 (2005) 36792-36801
42. Mazza G. Anthocyanins and heart health. Ann. Ist. Super. Sanita 43 (2007) 369-374
43. Teissedre P.L., Frankel E.N., Waterhouse A.L., Peleg H., and German J.B. Inhibition of in vitro human LDL oxidation by phenolic antioxidants from grapes and wines. J. Sci. Food Agric. 70 (1996) 55-61
44. Satué-Gracia M.T., Heinonen M., and Frankel E. Anthocyanins as antioxidants on human low-density lipoprotein and lecithin liposome systems. J. Agric. Food Chem. 45 (1997) 3362-3367
45. Aviram M., and Fuhrman B. Wine flavonoids protect against LDL oxidation and atherosclerosis. Ann. N.Y. Acad. Sci. 957 (2002) 146-161
46. Kühnau J. The flavonoids: a class of semi-essential food components: their role in human nutrition. World Rev. Nutr. Diet 24 (1976) 117-191
47. Passamonti S., Vrhovsek U., Vanzo A., and Mattivi F. The stomach as a site for anthocyanins absorption from food. FEBS Lett. 544 (2003) 210-213
48. Kay C.D., Mazza G., Holub B.J., and Wang J. Anthocyanin metabolites in human urine and serum. Br. J. Nutr. 91 (2004) 933-942
49. Nielsen I.L., Dragsted L.O., Ravn-Haren G., Freese R., and Rasmussen S.E. Absorption and excretion of black currant anthocyanins in humans and watanabe heritable hyperlipidemic rabbits. J. Agric. Food Chem. 51 (2003) 2813-2820